Elizabeth A Johnson|Tracy L Hellem - JoVE Visualize

Showing results (71-80 of 72) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 72 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study GroupsGary M Strauss, James E Herndon, Michael A Maddaus, et al.

Lung Cancer (Amsterdam, Netherlands)|November 30, 2007

Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)Elizabeth A Johnson, Randolph S Marks, Sumithra J Mandrekar, et al.

Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 72 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study GroupsGary M Strauss, James E Herndon, Michael A Maddaus, et al.

Lung Cancer (Amsterdam, Netherlands)|November 30, 2007

Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)Elizabeth A Johnson, Randolph S Marks, Sumithra J Mandrekar, et al.

Pageof 8